Stage IIA Prostate Cancer Terminated Phase 2 Trials for Cabazitaxel (DB06772)

IndicationStatusPhase
DBCOND0028878 (Stage IIA Prostate Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01469338Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With DocetaxelSupportive Care